Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 16.04
Day High 16.85
Open:16.13
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Exelixis, Inc. is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. Exelixis is focusing its development and commercialization efforts primarily on COMETRIQ' (cabozantinib), its wholly-owned inhibitor of multiple receptor tyrosine kinases. Another Exelixis-discovered compound, cobimetinib, a selective inhibitor of MEK, is being evaluated by Roche and Genentech (a member of the Roche Group) in a broad development program under a collaboration with Exelixis.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Exelixis Inc Falls 7.58% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Sep 11, 12:19PM CDT
Comtex SmarTrend(R) - CMTX
Tue Sep 11, 12:19PM CDT
Exelixis Inc (NASDAQ:EXEL) traded in a range yesterday that spanned from a low of $16.85 to a high of $18.76. Yesterday, the shares fell 7.6%, which took the trading range below the 3-day low of $18.14 on volume of 4.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Exelixis Announces New Recommendations for CABOMETYX(R) (Cabozantinib) Tablets in Updated National Comprehensive Cancer Network Clinical Practice Guidelines
BusinessWire - Fri Sep 7, 7:00AM CDT
BusinessWire - CMTX
Fri Sep 7, 7:00AM CDT
Exelixis, Inc. (NASDAQ:EXEL) today announced that the National Comprehensive Cancer Network (NCCN) updated its Clinical Practice Guidelines to include new recommendations for CABOMETYX(R) (cabozantinib) tablets. With the updates, CABOMETYX is recommended by the NCCN for the treatment of advanced renal cell carcinoma (RCC) regardless of patient risk status (favorable-, intermediate-, and poor-risk).
Exelixis Inc Shares Down 29.0% Since SmarTrend's Sell Call (EXEL)
Comtex SmarTrend(R) - Thu Sep 6, 12:29AM CDT
Comtex SmarTrend(R) - CMTX
Thu Sep 6, 12:29AM CDT
SmarTrend identified a Downtrend for Exelixis Inc (NASDAQ:EXEL) on February 28th, 2018 at $26.69. In approximately 6 months, Exelixis Inc has returned 29.02% as of today's recent price of $18.94.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 15.81 +5.79% increase
on 09/17/18
Period Open:19.20
Price movement based on the high, low and last over the given period.
19.61 -14.71% decrease
on 08/29/18
-2.48 (-12.89%) decrease
since 08/17/18
3-Month 15.81 +5.79% increase
on 09/17/18
Period Open:19.47
Price movement based on the high, low and last over the given period.
23.19 -27.88% decrease
on 08/02/18
-2.74 (-14.10%) decrease
since 06/18/18
52-Week 15.81 +5.79% increase
on 09/17/18
Period Open:27.58
Price movement based on the high, low and last over the given period.
32.50 -48.54% decrease
on 10/16/17
-10.85 (-39.36%) decrease
since 09/18/17

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement